Multiple studies demonstrated that CK2 is usually overexpressed in cancer, leading to the upregulation of oncogenic molecules such as protein-kinase B (AKT), Wnt and extracellular signal-regulated kinase (ERK) and to the downregulation of tumour suppressor molecules (such as Notch and Ikaros) [125]. Here, AKT1 is linked to cancer.